Effects of Treatment Discontinuation in Clinical Psychopharmacology
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Acute withdrawal sometimes transitions into a protracted withdrawal syndrome (PWS), which lasts much longer, from months to years.19,20,22”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [22]
In the citing paper
“Across psychotropics, acute withdrawal may last 1–8 weeks after complete discontinuation of the drug.”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [22]
In the citing paper
“In this respect, antidepressants do not differ from other dependence-forming central nervous system (CNS) drugs like benzodiazepines, opioids, gabapentinoids, or psychostimulants.3,19–22”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [22]
In the citing paper
“The evidence supporting this strategy, however, is based mainly on clinical trials where remitted patients were randomized to drug continuation or placebo, without any differentiation between withdrawal and relapse.”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [65]
In the citing paper
“we have no way to know how many of the relapses were actually withdrawal and post-withdrawal syndromes in the group that underwent drug tapering and discontinuation.”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [65]
Citations
Cites
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Viguera, A. C., Whitfield, T., Baldessarini, R. J., Newport, D. J., Stowe, Z., Reminick, A., Zurick, A., & Cohen, L. S. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06101639 · Cited by 599
Self-citationExploring comorbidity within mental disorders among a Danish national population
Plana-Ripoll, O., Pedersen, C. B., Holtz, Y., Benros, M. E., Dalsgaard, S., de Jonge, P., Fan, C. C., Degenhardt, L., Ganna, A., Greve, A. N., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3658 · Cited by 584
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Viguera, A. C., Nonacs, R., Cohen, L. S., Tondo, L., Murray, A., & Baldessarini, R. J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.179 · Cited by 488
Self-citationTarsy, D., & Baldessarini, R. J. (1974) · Neuropharmacology · doi:10.1016/0028-3908(74)90084-7 · Cited by 446
Self-citationFava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder
Suppes, T. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360046007 · Cited by 392
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Self-citationClinical Pharmacokinetics of Selective Serotonin Reuptake Inhibitors
van Harten, J. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324030-00003 · Cited by 311
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
Viguera, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130055011 · Cited by 246
Outcome After Rapid vs Gradual Discontinuation of Lithium Treatment in Bipolar Disorders
Faedda, G. L. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180046005 · Cited by 239
Discontinuation Symptoms After Treatment With Serotonin Reuptake Inhibitors: A Literature Review
Zajecka, J., Tracy, K. A., & Mitchell, S. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0702 · Cited by 209
Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?
Tarsy, D., & Baldessarini, R. J. (2006) · Movement Disorders · doi:10.1002/mds.20823 · Cited by 200
Self-citationNew Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications
Baldessarini, R. J., Tondo, L., & Viguera, A. C. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.10106.x · Cited by 153
Self-citationDiscontinuing antidepressant treatment in major depression.
Viguera, A. C., Baldessarini, R. J., & Friedberg, J. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809003578 · Cited by 145
Self-citationIllness risk following rapid versus gradual discontinuation of antidepressants
Baldessarini, R. J., Tondo, L., Ghiani, C., & Lepri, B. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09060880 · Cited by 123
Self-citationReview of withdrawal catatonia: what does this reveal about clozapine?
Lander, M., Bastiampillai, T. J., & Sareen, J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0192-9 · Cited by 122
Fluyau, D., Revadigar, N., & Manobianco, B. E. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317753340 · Cited by 109
New mechanisms and perspectives in nicotine withdrawal
Jackson, K. J., Muldoon, P. P., De Biasi, M., & Damaj, M. I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.009 · Cited by 104
Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment
Correll, C. U., Kane, J. M., & Citrome, L. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.tv17016ah4c · Cited by 96
Effects of the Rate of Discontinuing Lithium Maintenance Treatment in Bipolar Disorders
Baldessarini, R. J., Tondo, L., Faedda, G. L., Suppes, T. R., Floris, G., & Rudas, N. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1001 · Cited by 93
Self-citation(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.551 · Cited by 82
Self-citationFava, G. A., Bernardi, M., Tomba, E., & Rafanelli, C. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007462 · Cited by 80
Discontinuation of Maintenance Treatment in Bipolar Disorder: Risks and Implications
Suppes, T., Baldessarini, R. J., Faedda, G. L., Tondo, L., & Tohen, M. (1993) · Harvard Review of Psychiatry · doi:10.3109/10673229309017072 · Cited by 80
Self-citationDiscontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava, G. A., & Belaise, C. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000492693 · Cited by 77
Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.
Robinson, J. D., Li, L., Chen, M., Lerman, C., Tyndale, R. F., Schnoll, R. A., Hawk, L. W., George, T. P., Benowitz, N. L., & Cinciripini, P. M. (2019) · Psychology of Addictive Behaviors · doi:10.1037/adb0000434 · Cited by 74
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.548 · Cited by 61
Self-citationSubstance Use, Intoxication, and Withdrawal in the Critical Care Setting
Donroe, J. H., & Tetrault, J. M. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.03.003 · Cited by 55
Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression
Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y., & Sim, K. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000263 · Cited by 52
Self-citationTakeuchi, H., Kantor, N., Uchida, H., Suzuki, T., & Remington, G. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw171 · Cited by 40
Scholten, W. D., Batelaan, N. M., van Oppen, P., Smit, J. H., Hoogendoorn, A. W., van Megen, H. J. G. M., Cath, D. C., & van Balkom, A. J. L. M. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000489498 · Cited by 33
Khan, A., Musgnung, J., Ramey, T., Messig, M., Buckley, G., & Ninan, P. T. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000100 · Cited by 30
Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation
Schultz, S. K., Miller, D. D., Arndt, S., Ziebell, S., Gupta, S., & Andreasen, N. C. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00082-8 · Cited by 29
Neonatal Discontinuation Syndrome in Serotonergic Antidepressant–Exposed Neonates
Yang, A., Ciolino, J. D., Pinheiro, E. A., Rasmussen‐Torvik, L. J., Sit, D. K. Y., & Wisner, K. L. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11044 · Cited by 28
Gallagher, J. C., Strzinek, R. A., Cheng, R.-F. J., Ausmanas, M. K., Astl, D., & Seljan, P. (2012) · Journal of Women's Health · doi:10.1089/jwh.2011.2764 · Cited by 21
Tint, A., Haddad, P. M., & Anderson, I. M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107087488 · Cited by 13
Research works printed but not linked: 1
- 10.1177/0269881107081550 · doi:10.1177/0269881107081550 · Paper page
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Clinical use of lithium salts: guide for users and prescribers
for the International Group for Studies of Lithium (IGSLi), Tondo, L., Alda, M., Bauer, M., Bergink, V., Grof, P., Hajek, T., Lewitka, U., Licht, R. W., Manchia, M., et al. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0151-2 · Cited by 204
Self-citationGuidi, J., & Fava, G. A. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3650 · Cited by 155
Lithium Treatment Over the Lifespan in Bipolar Disorders
Volkmann, C., Bschor, T., & Köhler, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00377 · Cited by 145
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84
Metadata
- Authors
- Baldessarini, R. J., & Tondo, L.
- Affiliations
- Harvard University (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2019
- Volume
- 88
- Issue
- 2
- Pages
- 65-70
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2927696747
- Semantic Scholar
- 8758c4235f4af9cfcbd41efb71bb6da771e7dce6
- Cited by
- 52
- References
- 41
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 13 · 2020: 16 · 2019: 3
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- treatment discontinuation, psychopharmacology, antidepressants, relapse
- MeSH terms
- Mental Disorders, Humans, Psychopharmacology, Psychotropic Drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.